Tuesday, September 07, 2021 3:41:13 PM
there's also the veterinary connection too hl...
https://content.edgar-online.com/ExternalLink/EDGAR/0001360865-14-000037.html?hash=fd95ea1dcb6b1a1f22de2fd04b9ffdaaf9e9f37c7e141070df07c5a5e1524486&dest=EXHIBIT102_HTM#EXHIBIT102_HTM
Manufacturing Agreement
This contract is made effective as of May 8, 2014 by and between Petlife Corporation / Sebastian Serrell-Watts and Samson Pharmaceuticals Inc. / Jay Kassir.
Purpose of contract: Samson Pharmaceuticals Inc. is in the business of private label liquid filling manufacturing, FDA licensed and registered. Samson Pharmaceuticals Inc. agrees to produce oral solution products for Petlife Corporation.
SOHM PR
https://www.sohm.com/2021/04/27/sohm-inc-signs-a-mutual-letter-of-intent-for-an-acquisition-of-southern-california-based-pharmaceutical-company/#.YIgYE_Br5AM.twitter
Mr. Night added that the proposed target of pharmaceutical manufacturing company is in manufacturing and supply to third party and private label manufacturing for last 20 years. The company has more than 300+ formulation ranging from OTC to prescription to skincare to cosmeceuticals as well as veterinary segments. The company has license to manufacture, prescription, OTC and cosmeceutical products.
https://content.edgar-online.com/ExternalLink/EDGAR/0001360865-14-000037.html?hash=fd95ea1dcb6b1a1f22de2fd04b9ffdaaf9e9f37c7e141070df07c5a5e1524486&dest=EXHIBIT102_HTM#EXHIBIT102_HTM
Manufacturing Agreement
This contract is made effective as of May 8, 2014 by and between Petlife Corporation / Sebastian Serrell-Watts and Samson Pharmaceuticals Inc. / Jay Kassir.
Purpose of contract: Samson Pharmaceuticals Inc. is in the business of private label liquid filling manufacturing, FDA licensed and registered. Samson Pharmaceuticals Inc. agrees to produce oral solution products for Petlife Corporation.
SOHM PR
https://www.sohm.com/2021/04/27/sohm-inc-signs-a-mutual-letter-of-intent-for-an-acquisition-of-southern-california-based-pharmaceutical-company/#.YIgYE_Br5AM.twitter
Mr. Night added that the proposed target of pharmaceutical manufacturing company is in manufacturing and supply to third party and private label manufacturing for last 20 years. The company has more than 300+ formulation ranging from OTC to prescription to skincare to cosmeceuticals as well as veterinary segments. The company has license to manufacture, prescription, OTC and cosmeceutical products.
Recent SHMN News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery • ACCESS Newswire • 11/06/2025 02:30:00 PM
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development • ACCESS Newswire • 11/04/2025 02:30:00 PM
